Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
CPT: Pharmacometrics & Systems Pharmacology|April 6, 2017
Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib-Treated Patients With Gastrointestinal Stromal TumorsE Schindler, S M Krishnan, Rhj Mathijssen, et al.
La Radiologia Medica|December 1, 1991
[The hypothesis of a diagnostic-prognostic assessment of intestinal invagination with the aim of treatment by echo-guided pneumatic reduction]A Rabassini, G Schiavon, F Allaghi, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|September 11, 2009
[Foreign body ingestion: a common problem in paediatric age]M Gasparella, G Schiavon, C Benetton, et al.
Minerva Pediatrica|June 1, 1997
[Phimosis: when does it require surgical intervention?]M Marzaro, G Carmignola, F Zoppellaro, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|November 25, 2011
Iatrogenic traumas by nasogastric tube in very premature infants: our cases and literature reviewM Gasparella, G Schiavon, L Bordignon, et al.
Histology and Histopathology|January 27, 2006
Cell cycle alterations and lung cancerB Vincenzi, G Schiavon, M Silletta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2019
Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trialS Hrebien, V Citi, I Garcia-Murillas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2012
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?D Santini, B Vincenzi, R Addeo, et al.
The Pharmacogenomics Journal|June 6, 2007
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapyA Ruzzo, F Graziano, F Loupakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2019
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-populationN C Turner, E Alarcón, A C Armstrong, et al.
Pageof 2